by xediton | Feb 7, 2025 | Uncategorized
OAKVILLE, ONTARIO, February 5, 2025,— Xediton Pharmaceuticals Inc., (“Xediton” or the “Purchaser”) a Canadian Specialty Pharmaceutical company, announced today that it has closed a share purchase agreement with Valeo Pharma Inc. (“Valeo” or the “Company”), in its...
by xediton | May 15, 2023 | Uncategorized
Parsippany, New Jersey and Ontario, Canada, May 15, 2023 – Melinta Therapeutics, LLC (Melinta) and Xediton Pharmaceuticals Inc (Xediton) today announced they have entered into an exclusive commercialization and licensing agreement for BAXDELA® (delafloxacin), KIMYRSA®...